drug
METHYLIN ER
Marketedupdated 3mo agoby SpecGx LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval428 co-mentions · 201 sources
- drugMETADATE CD404 co-mentions · 206 sources
- drugMETADATE ER261 co-mentions · 206 sources
- drugMethylin245 co-mentions · 206 sources
- drugRITALIN LA244 co-mentions · 206 sources
- drugQuillivant XR233 co-mentions · 206 sources
- drugmethylphenidate hydrochloride ER224 co-mentions · 206 sources
- drugRelexxii222 co-mentions · 206 sources
all catalysts(13)
approval · 13
May 9, 2000
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Apr 24, 2003
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Dec 10, 2010
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Dec 19, 2012
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Jan 21, 2014
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Mar 20, 2015
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Oct 28, 2016
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Oct 28, 2016
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Jun 14, 2021
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Jun 14, 2021
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Jun 25, 2021
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Oct 2, 2025
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Oct 7, 2025
approval
METHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METHYLIN ER
→
Trials studying METHYLIN ER
- phase3Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD
- phase1Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions
- phase1Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions
- phase4A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that